Company intelligence / Profile preview

Neurosity

Brooklyn, New York, United Statesneurosity.co ↗

Ownership: Private
Development stage: Commercial

Overview

The company has launched two generations of wearable brain-computer interfaces—Notion and the current flagship Crown. These devices provide real-time EEG data to help users improve focus, productivity, relaxation, or manage stress. Clinical results are not published as in pharma trials; instead, user testimonials and case studies highlight improvements in focus metrics using the device. The technology has been adopted by consumers as well as researchers/developers building new neuro-applications.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (EEG-based neurofeedback and brain-computer interface)
Industry: Physiological Monitoring

Partnerships

none disclosed with major pharma or biotech companies; open developer program/community partnerships highlighted

Beyond the preview

Go deeper on Neurosity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurosity.

Explore the full profile